Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del
Clinical trial NCT05331183 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05331183
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-23
- Primary completion
- 2027-04-06
- Enrollment
- 297
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.